array:24 [
  "pii" => "S2666275221002368"
  "issn" => "26662752"
  "doi" => "10.1016/j.abdp.2020.08.020"
  "estado" => "S300"
  "fechaPublicacion" => "2021-11-01"
  "aid" => "455"
  "copyright" => "Sociedade Brasileira de Dermatologia"
  "copyrightAnyo" => "2021"
  "documento" => "article"
  "crossmark" => 1
  "licencia" => "http://creativecommons.org/licenses/by/4.0/"
  "subdocumento" => "sco"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:1 [
    "total" => 0
  ]
  "Traduccion" => array:1 [
    "en" => array:19 [
      "pii" => "S0365059621002300"
      "issn" => "03650596"
      "doi" => "10.1016/j.abd.2020.08.030"
      "estado" => "S300"
      "fechaPublicacion" => "2021-11-01"
      "aid" => "455"
      "copyright" => "Sociedade Brasileira de Dermatologia"
      "documento" => "article"
      "crossmark" => 1
      "licencia" => "http://creativecommons.org/licenses/by/4.0/"
      "subdocumento" => "sco"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:1 [
        "total" => 0
      ]
      "en" => array:10 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Research Letter</span>"
        "titulo" => "104-week safety and effectiveness of dupilumab in the treatment of severe atopic dermatitis&#46; The experience of 5 reference dermatology units in Spain"
        "tienePdf" => "en"
        "tieneTextoCompleto" => "en"
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "787"
            "paginaFinal" => "790"
          ]
        ]
        "contieneTextoCompleto" => array:1 [
          "en" => true
        ]
        "contienePdf" => array:1 [
          "en" => true
        ]
        "resumenGrafico" => array:2 [
          "original" => 0
          "multimedia" => array:8 [
            "identificador" => "fig0020"
            "etiqueta" => "Figure 4"
            "tipo" => "MULTIMEDIAFIGURA"
            "mostrarFloat" => true
            "mostrarDisplay" => false
            "figura" => array:1 [
              0 => array:4 [
                "imagen" => "gr4.jpeg"
                "Alto" => 446
                "Ancho" => 1305
                "Tamanyo" => 69275
              ]
            ]
            "detalles" => array:1 [
              0 => array:3 [
                "identificador" => "at0020"
                "detalle" => "Figure "
                "rol" => "short"
              ]
            ]
            "descripcion" => array:1 [
              "en" => "<p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">16w after Dupilumab treatment &#40;SCORAD 16&#41;&#46;</p>"
            ]
          ]
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "Jose Juan Pereyra-Rodriguez, Javier Dominguez-Cruz, Jose Carlos Armario-Hita, Ricardo Ruiz-Villaverde"
            "autores" => array:4 [
              0 => array:2 [
                "nombre" => "Jose Juan"
                "apellidos" => "Pereyra-Rodriguez"
              ]
              1 => array:2 [
                "nombre" => "Javier"
                "apellidos" => "Dominguez-Cruz"
              ]
              2 => array:2 [
                "nombre" => "Jose Carlos"
                "apellidos" => "Armario-Hita"
              ]
              3 => array:2 [
                "nombre" => "Ricardo"
                "apellidos" => "Ruiz-Villaverde"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "en"
      "Traduccion" => array:1 [
        "pt" => array:9 [
          "pii" => "S2666275221002368"
          "doi" => "10.1016/j.abdp.2020.08.020"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "pt"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2666275221002368?idApp=UINPBA00008Z"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0365059621002300?idApp=UINPBA00008Z"
      "url" => "/03650596/0000009600000006/v2_202111180901/S0365059621002300/v2_202111180901/en/main.assets"
    ]
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S2666275221002319"
    "issn" => "26662752"
    "doi" => "10.1016/j.abdp.2021.09.023"
    "estado" => "S300"
    "fechaPublicacion" => "2021-11-01"
    "aid" => "450"
    "copyright" => "Sociedade Brasileira de Dermatologia"
    "documento" => "article"
    "crossmark" => 1
    "licencia" => "http://creativecommons.org/licenses/by/4.0/"
    "subdocumento" => "sco"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:1 [
      "total" => 0
    ]
    "pt" => array:10 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Carta &#8208; Caso cl&#237;nico</span>"
      "titulo" => "Observa&#231;&#227;o cl&#237;nico&#8208;dermosc&#243;pica e imunohistoqu&#237;mica de m&#225;culas telangiect&#225;sicas bilaterais adquiridas associadas ao v&#237;rus da hepatite B em um homem chin&#234;s"
      "tienePdf" => "pt"
      "tieneTextoCompleto" => "pt"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "791"
          "paginaFinal" => "793"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "pt" => true
      ]
      "contienePdf" => array:1 [
        "pt" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0015"
          "etiqueta" => "Figura 3"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr3.jpeg"
              "Alto" => 1100
              "Ancho" => 2917
              "Tamanyo" => 278424
            ]
          ]
          "descripcion" => array:1 [
            "pt" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">An&#225;lise imuno&#8208;histoqu&#237;mica revelando mast&#243;citos e melan&#243;citos na ABTM&#46; &#40;A&#41;&#44; Alguns mast&#243;citos positivos para CD117 &#40;setas&#41; ao redor dos capilares dilatados na derme papilar &#40;200&#215;&#41;&#46; &#40;B&#41;&#44; Melan&#243;citos normais positivos para Melan&#8208;A na epiderme &#40;200&#215;&#41;&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Zi&#8208;Wei Zhang, Hao Wu, Ke&#8208;Feng Tang, Yi&#8208;Ming Fan"
          "autores" => array:4 [
            0 => array:2 [
              "nombre" => "Zi&#8208;Wei"
              "apellidos" => "Zhang"
            ]
            1 => array:2 [
              "nombre" => "Hao"
              "apellidos" => "Wu"
            ]
            2 => array:2 [
              "nombre" => "Ke&#8208;Feng"
              "apellidos" => "Tang"
            ]
            3 => array:2 [
              "nombre" => "Yi&#8208;Ming"
              "apellidos" => "Fan"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "pt"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S0365059621002257"
        "doi" => "10.1016/j.abd.2020.08.027"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0365059621002257?idApp=UINPBA00008Z"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2666275221002319?idApp=UINPBA00008Z"
    "url" => "/26662752/0000009600000006/v2_202111200533/S2666275221002319/v2_202111200533/pt/main.assets"
  ]
  "itemAnterior" => array:19 [
    "pii" => "S2666275221002204"
    "issn" => "26662752"
    "doi" => "10.1016/j.abdp.2021.09.012"
    "estado" => "S300"
    "fechaPublicacion" => "2021-11-01"
    "aid" => "439"
    "copyright" => "Sociedade Brasileira de Dermatologia"
    "documento" => "article"
    "crossmark" => 1
    "licencia" => "http://creativecommons.org/licenses/by/4.0/"
    "subdocumento" => "sco"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:1 [
      "total" => 0
    ]
    "pt" => array:10 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Carta &#8208; Investiga&#231;&#227;o</span>"
      "titulo" => "Avalia&#231;&#227;o da efic&#225;cia do&#160;5&#8208;fluorouracil 5&#37;&#160;t&#243;pico intermitente e da nicotinamida oral no tratamento do campo de canceriza&#231;&#227;o cut&#226;neo&#58; um ensaio cl&#237;nico randomizado"
      "tienePdf" => "pt"
      "tieneTextoCompleto" => "pt"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "784"
          "paginaFinal" => "787"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "pt" => true
      ]
      "contienePdf" => array:1 [
        "pt" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0005"
          "etiqueta" => "Figura 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 1440
              "Ancho" => 2167
              "Tamanyo" => 135747
            ]
          ]
          "descripcion" => array:1 [
            "pt" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Contagem das ceratoses act&#237;nicas no T0 e no T120 para os grupos nicotinamida oral&#44; placebo&#44; 5FU e filtro solar t&#243;picos&#58; melhora em todos os grupos com o tempo&#44; com superioridade ao grupo em uso de 5FU t&#243;pico&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Eliane Roio Ferreira, Anna Carolina Miola, Thania Rios Rossi Lima, Juliano Vilaverde Schmitt, Luciana Patricia Fernandes Abbade, H&#233;lio Amante Miot"
          "autores" => array:6 [
            0 => array:2 [
              "nombre" => "Eliane Roio"
              "apellidos" => "Ferreira"
            ]
            1 => array:2 [
              "nombre" => "Anna Carolina"
              "apellidos" => "Miola"
            ]
            2 => array:2 [
              "nombre" => "Thania Rios Rossi"
              "apellidos" => "Lima"
            ]
            3 => array:2 [
              "nombre" => "Juliano Vilaverde"
              "apellidos" => "Schmitt"
            ]
            4 => array:2 [
              "nombre" => "Luciana Patricia Fernandes"
              "apellidos" => "Abbade"
            ]
            5 => array:2 [
              "nombre" => "H&#233;lio Amante"
              "apellidos" => "Miot"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "pt"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S0365059621002142"
        "doi" => "10.1016/j.abd.2020.09.012"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0365059621002142?idApp=UINPBA00008Z"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2666275221002204?idApp=UINPBA00008Z"
    "url" => "/26662752/0000009600000006/v2_202111200533/S2666275221002204/v2_202111200533/pt/main.assets"
  ]
  "pt" => array:17 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Carta &#8208; Investiga&#231;&#227;o</span>"
    "titulo" => "Seguran&#231;a e efic&#225;cia de 104 semanas de dupilumabe no tratamento de dermatite at&#243;pica grave&#46; A experi&#234;ncia de cinco unidades dermatol&#243;gicas de refer&#234;ncia na Espanha"
    "tieneTextoCompleto" => true
    "saludo" => "<span class="elsevierStyleItalic">Prezado Editor&#44;</span>"
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "787"
        "paginaFinal" => "790"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "Jose Juan Pereyra&#8208;Rodriguez, Javier Dominguez&#8208;Cruz, Jose Carlos Armario&#8208;Hita, Ricardo Ruiz&#8208;Villaverde"
        "autores" => array:4 [
          0 => array:3 [
            "nombre" => "Jose Juan"
            "apellidos" => "Pereyra&#8208;Rodriguez"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
          1 => array:3 [
            "nombre" => "Javier"
            "apellidos" => "Dominguez&#8208;Cruz"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
          2 => array:3 [
            "nombre" => "Jose Carlos"
            "apellidos" => "Armario&#8208;Hita"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
            ]
          ]
          3 => array:4 [
            "nombre" => "Ricardo"
            "apellidos" => "Ruiz&#8208;Villaverde"
            "email" => array:1 [
              0 => "ricardo.ruiz.villaverde.sspa@juntadeandalucia.es"
            ]
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">c</span>"
                "identificador" => "aff0015"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:3 [
          0 => array:3 [
            "entidad" => "Unidade de Dermatologia&#44; Hospital Universitario Virgen del Rocio&#44; Sevilha&#44; Espanha"
            "etiqueta" => "a"
            "identificador" => "aff0005"
          ]
          1 => array:3 [
            "entidad" => "Unidade de Dermatologia&#44; Hospital Universitario Puerto Real&#44; C&#225;diz&#44; Espanha"
            "etiqueta" => "b"
            "identificador" => "aff0010"
          ]
          2 => array:3 [
            "entidad" => "Unidade de Dermatologia&#44; Hospital Universitario San Cecilio&#44; Granada&#44; Espanha"
            "etiqueta" => "c"
            "identificador" => "aff0015"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Autor para correspond&#234;ncia&#46;"
          ]
        ]
      ]
    ]
    "resumenGrafico" => array:2 [
      "original" => 0
      "multimedia" => array:7 [
        "identificador" => "fig0010"
        "etiqueta" => "Figura 2"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr2.jpeg"
            "Alto" => 1366
            "Ancho" => 2175
            "Tamanyo" => 91016
          ]
        ]
        "descripcion" => array:1 [
          "pt" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Evolu&#231;&#227;o do DLQI da linha de base at&#233; a semana 104&#46; <span class="elsevierStyleItalic">DLQI</span>&#44; <span class="elsevierStyleItalic">Dermatology Life Quality Index</span>&#46;</p>"
        ]
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">A dermatite at&#243;pica &#40;DA&#41; &#233; uma doen&#231;a multifatorial resultante da intera&#231;&#227;o de predisposi&#231;&#227;o gen&#233;tica&#44; gatilhos ambientais&#44; perda da fun&#231;&#227;o de barreira da pele e desregula&#231;&#227;o imunol&#243;gica do tipo 2&#46; O manejo das formas leves de DA inclui o uso de emolientes&#44; corticosteroides t&#243;picos ou inibidores da calcineurina e fototerapia&#44; enquanto os agentes imunossupressores sist&#234;micos&#44; como corticosteroides orais e ciclosporina A &#40;CsA&#41;&#44; s&#227;o indicados para casos refrat&#225;rios graves&#46;<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">1</span></a> Entretanto&#44; os casos graves geralmente n&#227;o s&#227;o controlados de maneira adequada com nenhuma dessas terapias&#44; exigindo uma etapa adicional para atingir o controle cl&#237;nico&#46;<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">2</span></a> Recentemente&#44; a FDA e a EMA autorizaram o uso de dupilumabe&#44; um tratamento direcionado &#224;s citocinas Th2 IL&#8208;4 e IL&#8208;13 que se mostrou eficaz no controle dos sinais e sintomas de DA&#46; A experi&#234;ncia cl&#237;nica com o dupilumabe mostra uma efic&#225;cia semelhante em compara&#231;&#227;o com os ensaios cl&#237;nicos randomizados&#44; mas ainda n&#227;o se sabe como esse medicamento se comportar&#225; em longo prazo na pr&#225;tica m&#233;dica de rotina&#46;<a class="elsevierStyleCrossRefs" href="#bib0040"><span class="elsevierStyleSup">3&#8211;5</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">Realizou&#8208;se uma revis&#227;o retrospectiva de prontu&#225;rios de 30 pacientes de cinco unidades de dermatologia de refer&#234;ncia da Andaluzia &#40;Hospital Virgen del Rocio&#8208;Sevilla&#59; Hospital Juan Ramon Jimenez&#8208;Huelva&#59; Hospital Universitario de Puerto Real&#8208;C&#225;diz&#59; Hospital Reina Sofia&#8208;C&#243;rdoba e Hospital Universitario San Cecilio&#8208;Granada&#41; inclu&#237;dos no uso compassivo na Espanha de dupilumabe para pacientes adultos com DA moderada a grave&#44; de novembro de 2017 a fevereiro de 2020&#46; De acordo com as recomenda&#231;&#245;es do programa de uso compassivo para prescri&#231;&#227;o de dupilumabe&#44; os crit&#233;rios de inclus&#227;o foram idade &#8805; 18 anos&#44; doen&#231;a grave definida por &#205;ndice de &#193;rea e Gravidade de Eczema &#40;EASI&#44; <span class="elsevierStyleItalic">Eczema Area and Severity Index</span>&#41; basal &#8805; 16 e resposta inadequada&#47;intoler&#226;ncia a CsA ou desaconselhamento m&#233;dico para o tratamento com CsA&#46; Pacientes com qualquer comorbidade psiqui&#225;trica documentada foram exclu&#237;dos do estudo&#46;</p><p id="par0015" class="elsevierStylePara elsevierViewall">Todos os pacientes foram tratados com dupilumabe subcut&#226;neo 300<span class="elsevierStyleHsp" style=""></span>mg a cada duas semanas ap&#243;s uma dose de ataque de 600<span class="elsevierStyleHsp" style=""></span>mg&#46; Tratamentos concomitantes com corticosteroides t&#243;picos ou inibidores da calcineurina foram permitidos&#46; Todos os pacientes concordaram com o regime de tratamento e assinaram um termo de consentimento por escrito para autorizar a extra&#231;&#227;o de dados relevantes de seus prontu&#225;rios&#46; Os dados coletados inclu&#237;ram idade&#44; tempo de evolu&#231;&#227;o da doen&#231;a&#44; hist&#243;ria pessoal &#40;incluindo comorbidades&#41; e tratamentos sist&#234;micos&#47; biol&#243;gicos anteriores&#46; A gravidade da doen&#231;a foi medida pela ferramenta Scoring Atopic Dermatitis &#40;SCORAD&#41; e Escala Visual Anal&#243;gica &#40;EVA&#41; de prurido na consulta inicial e nas semanas de acompanhamento 4&#44; 12&#44; 24&#44; 52&#44; 76 e 104&#46; A qualidade de vida foi avaliada pelo <span class="elsevierStyleItalic">Dermatology Life Quality Index</span> &#40;DLQI&#41;&#46;</p><p id="par0020" class="elsevierStylePara elsevierViewall">As caracter&#237;sticas basais s&#227;o apresentadas na <a class="elsevierStyleCrossRef" href="#tbl0005">tabela 1</a>&#46; A popula&#231;&#227;o estudada apresentou uma carga de doen&#231;a substancial&#44; com uma m&#233;dia de 25&#44;7 anos de evolu&#231;&#227;o de DA&#46; As comorbidades mais comuns foram rinite al&#233;rgica &#40;55&#44;5&#37;&#41;&#44; asma &#40;37&#37;&#41; e conjuntivite &#40;33&#44;4&#37;&#41;&#46; Essas comorbidades foram mais comuns em pacientes com tratamento mais prolongado com imunossupressores&#46; Todos os pacientes tinham recebido tratamento anterior com corticosteroides orais e 96&#44;3&#37; tinham sido tratados com ciclosporina&#46;<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">3</span></a> A efetividade do tratamento com dupilumabe foi avaliada nas semanas 4&#44; 12&#44; 24&#44; 52 e 104&#46; A porcentagem m&#233;dia de mudan&#231;a na SCORAD &#233; mostrada na <a class="elsevierStyleCrossRef" href="#fig0005">figura 1</a>&#44; enquanto a evolu&#231;&#227;o do DLQI &#233; mostrada na <a class="elsevierStyleCrossRef" href="#fig0010">figura 2</a>&#46;</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><elsevierMultimedia ident="fig0005"></elsevierMultimedia><elsevierMultimedia ident="fig0010"></elsevierMultimedia><p id="par0025" class="elsevierStylePara elsevierViewall">Na linha de base&#44; o escore na SCORAD era de 59&#44;4&#44; enquanto a EVA de prurido era de 8&#44;3&#46; Na consulta de seguimento da semana 104&#44; o SCORAD diminuiu para 10&#44;7 &#40;&#8722;82&#37;&#41; e a EVA de prurido reduziu para 2&#44;9 &#40;&#8722;65&#37;&#41;&#46; Em rela&#231;&#227;o &#224; QV&#44; o valor basal do DLQI foi 19&#44; chegando a 4&#44;3 &#40;&#8722;77&#44;4&#37;&#41; no mesmo ponto de corte&#46; O perfil de seguran&#231;a foi favor&#225;vel&#44; com relato de tr&#234;s casos de conjuntivite leve&#44; tratada positivamente sem suspens&#227;o de Dupilumabe&#46; Um exemplo da evolu&#231;&#227;o ap&#243;s 16 semanas de tratamento &#233; mostrado na linha basal &#40;<a class="elsevierStyleCrossRef" href="#fig0015">fig&#46; 3</a>&#41; e ap&#243;s 16 semanas &#40;<a class="elsevierStyleCrossRef" href="#fig0020">fig&#46; 4</a>&#41;&#46;</p><elsevierMultimedia ident="fig0015"></elsevierMultimedia><elsevierMultimedia ident="fig0020"></elsevierMultimedia><p id="par0030" class="elsevierStylePara elsevierViewall">Este estudo multic&#234;ntrico retrospectivo em uma coorte de 30 pacientes com DA grave implica no seguimento mais longo publicado at&#233; o momento da experi&#234;ncia cl&#237;nica com dupilumabe e confirma a efic&#225;cia desse agente para casos refrat&#225;rios&#46; Uma redu&#231;&#227;o estatisticamente significativa no SCORAD foi alcan&#231;ada na semana 4 e mantida at&#233; a semana 104&#46; A melhora cl&#237;nica foi acompanhada por uma melhora consider&#225;vel da qualidade de vida&#44; medida pelo DLQI&#44; e o sintoma mais inc&#244;modo&#44; prurido&#44; foi avaliado por meio da EVA de prurido&#46; O dupilumabe foi bem tolerado na maioria dos indiv&#237;duos&#59; apenas 10&#37; dos pacientes apresentaram conjuntivite&#46; Esses resultados est&#227;o de acordo com o que foi registrado em ensaios cl&#237;nicos&#44; mas contrastam com outros estudos cl&#237;nicos&#44; que relataram sintomas oculares em at&#233; 62&#37; dos casos&#46;<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">5</span></a> De acordo com nossa experi&#234;ncia&#44; o uso de col&#237;rios de emuls&#227;o lip&#237;dica combinado a col&#237;rios com &#225;cido hialur&#244;nico como medida profil&#225;tica pode ter um efeito protetor contra olhos secos e prurido ocular&#44; que podem ter um papel fundamental no desenvolvimento de conjuntivite&#46; Rea&#231;&#245;es no local da inje&#231;&#227;o n&#227;o foram relatadas pelos pacientes&#46; As limita&#231;&#245;es do estudo incluem sua natureza retrospectiva e o pequeno tamanho da amostra&#46;</p><p id="par0035" class="elsevierStylePara elsevierViewall">Este estudo cl&#237;nico confirmou que o dupilumabe &#233; um tratamento eficaz em pacientes com DA grave e fornece o seguimento mais longo publicado at&#233; o momento&#46;</p><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0005">Suporte financeiro</span><p id="par0040" class="elsevierStylePara elsevierViewall">Nenhum&#46;</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Contribui&#231;&#227;o dos autores</span><p id="par0045" class="elsevierStylePara elsevierViewall">Jose Juan Pereyra&#8208;Rodriguez&#58; Obten&#231;&#227;o de dados&#59; edi&#231;&#227;o&#59; concep&#231;&#227;o e desenho do estudo&#59; reda&#231;&#227;o&#59; revis&#227;o cr&#237;tica&#46;</p><p id="par0050" class="elsevierStylePara elsevierViewall">Javier Dominguez&#8208;Cruz&#58; Obten&#231;&#227;o de dados&#59; edi&#231;&#227;o&#59; projeto&#59; revis&#227;o cr&#237;tica&#46;</p><p id="par0055" class="elsevierStylePara elsevierViewall">Jose Carlos Armario&#8208;Hita&#58; Obten&#231;&#227;o de dados&#59; edi&#231;&#227;o&#59; projeto&#59; revis&#227;o cr&#237;tica&#46;</p><p id="par0060" class="elsevierStylePara elsevierViewall">Ricardo Ruiz Villaverde&#58; Obten&#231;&#227;o de dados&#59; edi&#231;&#227;o&#59; concep&#231;&#227;o e desenho do estudo&#59; reda&#231;&#227;o&#59; revis&#227;o cr&#237;tica&#46;</p></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Conflito de interesses</span><p id="par0065" class="elsevierStylePara elsevierViewall">Nenhum&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:4 [
        0 => array:2 [
          "identificador" => "sec0005"
          "titulo" => "Suporte financeiro"
        ]
        1 => array:2 [
          "identificador" => "sec0010"
          "titulo" => "Contribui&#231;&#227;o dos autores"
        ]
        2 => array:2 [
          "identificador" => "sec0015"
          "titulo" => "Conflito de interesses"
        ]
        3 => array:1 [
          "titulo" => "Refer&#234;ncias"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "fechaRecibido" => "2020-04-20"
    "fechaAceptado" => "2020-08-24"
    "NotaPie" => array:2 [
      0 => array:2 [
        "etiqueta" => "&#9734;"
        "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Como citar este artigo&#58; Pereyra&#8208;Rodriguez JJ&#44; Dominguez&#8208;Cruz J&#44; Armario&#8208;Hita JC&#44; Villaverde RR&#46; 104&#8208;week safety and effectiveness of dupilumab in the treatment of severe atopic dermatitis&#46; The experience of 5 reference dermatology units in Spain&#46; An Bras Dermatol&#46; 2021&#59;96&#58;787&#8211;90&#46;</p>"
      ]
      1 => array:2 [
        "etiqueta" => "&#9734;&#9734;"
        "nota" => "<p class="elsevierStyleNotepara" id="npar0010">Trabalho realizado no Hospital Universitario San Cecilio&#44; Granada&#44; Espanha&#46;</p>"
      ]
    ]
    "multimedia" => array:5 [
      0 => array:7 [
        "identificador" => "fig0005"
        "etiqueta" => "Figura 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 1184
            "Ancho" => 2175
            "Tamanyo" => 87428
          ]
        ]
        "descripcion" => array:1 [
          "pt" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Altera&#231;&#227;o percentual m&#233;dia no escore de dermatite at&#243;pica &#40;SCORAD&#44; <span class="elsevierStyleItalic">Scoring Atopic Dermatitis</span>&#41; desde a linha de base at&#233; a semana 104 em pacientes tratados com dupilumabe&#46;</p>"
        ]
      ]
      1 => array:7 [
        "identificador" => "fig0010"
        "etiqueta" => "Figura 2"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr2.jpeg"
            "Alto" => 1366
            "Ancho" => 2175
            "Tamanyo" => 91016
          ]
        ]
        "descripcion" => array:1 [
          "pt" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Evolu&#231;&#227;o do DLQI da linha de base at&#233; a semana 104&#46; <span class="elsevierStyleItalic">DLQI</span>&#44; <span class="elsevierStyleItalic">Dermatology Life Quality Index</span>&#46;</p>"
        ]
      ]
      2 => array:7 [
        "identificador" => "fig0015"
        "etiqueta" => "Figura 3"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr3.jpeg"
            "Alto" => 565
            "Ancho" => 1305
            "Tamanyo" => 86068
          ]
        ]
        "descripcion" => array:1 [
          "pt" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Estado basal em um paciente da presente s&#233;rie &#40;SCORAD 64&#41;&#46;</p>"
        ]
      ]
      3 => array:7 [
        "identificador" => "fig0020"
        "etiqueta" => "Figura 4"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr4.jpeg"
            "Alto" => 446
            "Ancho" => 1305
            "Tamanyo" => 69275
          ]
        ]
        "descripcion" => array:1 [
          "pt" => "<p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Dezesseis semanas ap&#243;s tratamento com Dupilumab &#40;SCORAD 16&#41;&#46;</p>"
        ]
      ]
      4 => array:8 [
        "identificador" => "tbl0005"
        "etiqueta" => "Tabela 1"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at1"
            "detalle" => "Tabela "
            "rol" => "short"
          ]
        ]
        "tabla" => array:1 [
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Caracter&#237;stica&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">M&#233;dia&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleItalic">Idade&#44; anos &#40;varia&#231;&#227;o&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">40&#44;4 &#40;19&#8211;56&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleItalic">Sexo &#40;masculino&#44; &#37;&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">70&#37; &#40;21&#47;30&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleItalic">Anos de evolu&#231;&#227;o de DA&#44; anos &#40;varia&#231;&#227;o&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">28&#44;5 &#40;10&#8211;44&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " colspan="2" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleItalic">Comorbidades &#40;&#37;&#41;</span></td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>P&#243;lipos nasais&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">16&#44;6&#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Conjuntivite&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">36&#44;8&#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Asma extr&#237;nseca&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">22&#44;2&#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Rinite al&#233;rgica&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">50&#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Alergias alimentares&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">22&#44;2&#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " colspan="2" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " colspan="2" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleItalic">Tratamento anterior</span></td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Corticosteroides sist&#234;micos orais&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">100&#37; &#40;dura&#231;&#227;o m&#233;dia&#58; 23&#44;7 meses&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Ciclosporina oral&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">94&#44;4&#37; &#40;dura&#231;&#227;o m&#233;dia&#58; 19&#44;8 meses&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Fototerapia &#40;NB&#8208;UVB&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">33&#44;3&#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>SCORAD basal&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">59&#44;4&#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>EVA de prurido basal&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">8&#44;3&#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>DLQI basal&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">19&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab2750910.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "pt" => "<p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Caracter&#237;sticas basais dos pacientes</p>"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "Refer&#234;ncias"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0015"
          "bibliografiaReferencia" => array:5 [
            0 => array:3 [
              "identificador" => "bib0030"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Atopic dermatitis in adults&#58; a diagnostic challenge"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "J&#46;F&#46; Silvestre Salvador"
                            1 => "D&#46; Romero-P&#233;rez"
                            2 => "B&#46; Encabo-Dur&#225;n"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.18176/jiaci.0138"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Investig Allergol Clin Immunol&#46;"
                        "fecha" => "2017"
                        "volumen" => "27"
                        "paginaInicial" => "78"
                        "paginaFinal" => "88"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28071589"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0035"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Changing perspectives in atopic dermatitis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "E&#46; Serra-Baldrich"
                            1 => "J&#46;O&#46; de Frutos"
                            2 => "I&#46; J&#225;uregui"
                            3 => "J&#46;C&#46; Armario-Hita"
                            4 => "J&#46;F&#46; Silvestre"
                            5 => "L&#46; Herraez"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Allergol Immunopathol&#46;"
                        "fecha" => "2018"
                        "volumen" => "46"
                        "paginaInicial" => "397"
                        "paginaFinal" => "412"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0040"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Dupilumab&#58; short&#8208;term effectiveness and security in real clinical practice &#8211; A retrospective multicentric study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "R&#46; Ruiz-Villaverde"
                            1 => "J&#46; Dominguez-Cruz"
                            2 => "J&#46;C&#46; Armario-Hita"
                            3 => "L&#46; Martinez-Pilar"
                            4 => "S&#46; Alcantara-Luna"
                            5 => "J&#46;J&#46; Pereyra-Rodriguez"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/jdv.15118"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Eur Acad Dermatol Venereol&#46;"
                        "fecha" => "2019"
                        "volumen" => "33"
                        "paginaInicial" => "e21"
                        "paginaFinal" => "e22"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29888527"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0045"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Treatment of moderate&#8208;to&#8208;severe atopic dermatitis with dupilumab in real clinical practice&#58; a multicentre&#44; retrospective case series"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46;C&#46; Armario-Hita"
                            1 => "J&#46; Pereyra-Rodriguez"
                            2 => "J&#46;F&#46; Silvestre"
                            3 => "R&#46; Ruiz-Villaverde"
                            4 => "A&#46; Valero"
                            5 => "R&#46; Izu-Belloso"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/bjd.18041"
                      "Revista" => array:6 [
                        "tituloSerie" => "Br J Dermatol&#46;"
                        "fecha" => "2019"
                        "volumen" => "181"
                        "paginaInicial" => "1072"
                        "paginaFinal" => "1074"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/31021399"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0050"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Clinical Response and Quality of Life in Patients with Severe Atopic Dermatitis Treated with Dupilumab&#58; A Single&#8208;Center Real&#8208;Life Experience"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "S&#46; Ferrucci"
                            1 => "G&#46; Casazza"
                            2 => "L&#46; Angileri"
                            3 => "S&#46; Tavecchio"
                            4 => "F&#46; Germiniasi"
                            5 => "E&#46; Berti"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:4 [
                        "tituloSerie" => "J Clin Med&#46;"
                        "fecha" => "2020"
                        "volumen" => "9"
                        "paginaInicial" => "791"
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "pt"
  "url" => "/26662752/0000009600000006/v2_202111200533/S2666275221002368/v2_202111200533/pt/main.assets"
  "Apartado" => array:4 [
    "identificador" => "82068"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Carta - Investiga&#231;&#227;o"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/26662752/0000009600000006/v2_202111200533/S2666275221002368/v2_202111200533/pt/main.pdf?idApp=UINPBA00008Z&text.app=https://clinics.elsevier.es/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2666275221002368?idApp=UINPBA00008Z"
]
Share
Journal Information

Statistics

Follow this link to access the full text of the article

Carta ‐ Investigação
Segurança e eficácia de 104 semanas de dupilumabe no tratamento de dermatite atópica grave. A experiência de cinco unidades dermatológicas de referência na Espanha
Jose Juan Pereyra‐Rodrigueza, Javier Dominguez‐Cruza, Jose Carlos Armario‐Hitab, Ricardo Ruiz‐Villaverdec,
Corresponding author
a Unidade de Dermatologia, Hospital Universitario Virgen del Rocio, Sevilha, Espanha
b Unidade de Dermatologia, Hospital Universitario Puerto Real, Cádiz, Espanha
c Unidade de Dermatologia, Hospital Universitario San Cecilio, Granada, Espanha
Read
8532
Times
was read the article
2708
Total PDF
5824
Total HTML
Share statistics
 array:24 [
  "pii" => "S2666275221002368"
  "issn" => "26662752"
  "doi" => "10.1016/j.abdp.2020.08.020"
  "estado" => "S300"
  "fechaPublicacion" => "2021-11-01"
  "aid" => "455"
  "copyright" => "Sociedade Brasileira de Dermatologia"
  "copyrightAnyo" => "2021"
  "documento" => "article"
  "crossmark" => 1
  "licencia" => "http://creativecommons.org/licenses/by/4.0/"
  "subdocumento" => "sco"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:1 [
    "total" => 0
  ]
  "Traduccion" => array:1 [
    "en" => array:19 [
      "pii" => "S0365059621002300"
      "issn" => "03650596"
      "doi" => "10.1016/j.abd.2020.08.030"
      "estado" => "S300"
      "fechaPublicacion" => "2021-11-01"
      "aid" => "455"
      "copyright" => "Sociedade Brasileira de Dermatologia"
      "documento" => "article"
      "crossmark" => 1
      "licencia" => "http://creativecommons.org/licenses/by/4.0/"
      "subdocumento" => "sco"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:1 [
        "total" => 0
      ]
      "en" => array:10 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Research Letter</span>"
        "titulo" => "104-week safety and effectiveness of dupilumab in the treatment of severe atopic dermatitis&#46; The experience of 5 reference dermatology units in Spain"
        "tienePdf" => "en"
        "tieneTextoCompleto" => "en"
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "787"
            "paginaFinal" => "790"
          ]
        ]
        "contieneTextoCompleto" => array:1 [
          "en" => true
        ]
        "contienePdf" => array:1 [
          "en" => true
        ]
        "resumenGrafico" => array:2 [
          "original" => 0
          "multimedia" => array:8 [
            "identificador" => "fig0020"
            "etiqueta" => "Figure 4"
            "tipo" => "MULTIMEDIAFIGURA"
            "mostrarFloat" => true
            "mostrarDisplay" => false
            "figura" => array:1 [
              0 => array:4 [
                "imagen" => "gr4.jpeg"
                "Alto" => 446
                "Ancho" => 1305
                "Tamanyo" => 69275
              ]
            ]
            "detalles" => array:1 [
              0 => array:3 [
                "identificador" => "at0020"
                "detalle" => "Figure "
                "rol" => "short"
              ]
            ]
            "descripcion" => array:1 [
              "en" => "<p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">16w after Dupilumab treatment &#40;SCORAD 16&#41;&#46;</p>"
            ]
          ]
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "Jose Juan Pereyra-Rodriguez, Javier Dominguez-Cruz, Jose Carlos Armario-Hita, Ricardo Ruiz-Villaverde"
            "autores" => array:4 [
              0 => array:2 [
                "nombre" => "Jose Juan"
                "apellidos" => "Pereyra-Rodriguez"
              ]
              1 => array:2 [
                "nombre" => "Javier"
                "apellidos" => "Dominguez-Cruz"
              ]
              2 => array:2 [
                "nombre" => "Jose Carlos"
                "apellidos" => "Armario-Hita"
              ]
              3 => array:2 [
                "nombre" => "Ricardo"
                "apellidos" => "Ruiz-Villaverde"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "en"
      "Traduccion" => array:1 [
        "pt" => array:9 [
          "pii" => "S2666275221002368"
          "doi" => "10.1016/j.abdp.2020.08.020"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "pt"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2666275221002368?idApp=UINPBA00008Z"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0365059621002300?idApp=UINPBA00008Z"
      "url" => "/03650596/0000009600000006/v2_202111180901/S0365059621002300/v2_202111180901/en/main.assets"
    ]
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S2666275221002319"
    "issn" => "26662752"
    "doi" => "10.1016/j.abdp.2021.09.023"
    "estado" => "S300"
    "fechaPublicacion" => "2021-11-01"
    "aid" => "450"
    "copyright" => "Sociedade Brasileira de Dermatologia"
    "documento" => "article"
    "crossmark" => 1
    "licencia" => "http://creativecommons.org/licenses/by/4.0/"
    "subdocumento" => "sco"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:1 [
      "total" => 0
    ]
    "pt" => array:10 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Carta &#8208; Caso cl&#237;nico</span>"
      "titulo" => "Observa&#231;&#227;o cl&#237;nico&#8208;dermosc&#243;pica e imunohistoqu&#237;mica de m&#225;culas telangiect&#225;sicas bilaterais adquiridas associadas ao v&#237;rus da hepatite B em um homem chin&#234;s"
      "tienePdf" => "pt"
      "tieneTextoCompleto" => "pt"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "791"
          "paginaFinal" => "793"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "pt" => true
      ]
      "contienePdf" => array:1 [
        "pt" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0015"
          "etiqueta" => "Figura 3"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr3.jpeg"
              "Alto" => 1100
              "Ancho" => 2917
              "Tamanyo" => 278424
            ]
          ]
          "descripcion" => array:1 [
            "pt" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">An&#225;lise imuno&#8208;histoqu&#237;mica revelando mast&#243;citos e melan&#243;citos na ABTM&#46; &#40;A&#41;&#44; Alguns mast&#243;citos positivos para CD117 &#40;setas&#41; ao redor dos capilares dilatados na derme papilar &#40;200&#215;&#41;&#46; &#40;B&#41;&#44; Melan&#243;citos normais positivos para Melan&#8208;A na epiderme &#40;200&#215;&#41;&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Zi&#8208;Wei Zhang, Hao Wu, Ke&#8208;Feng Tang, Yi&#8208;Ming Fan"
          "autores" => array:4 [
            0 => array:2 [
              "nombre" => "Zi&#8208;Wei"
              "apellidos" => "Zhang"
            ]
            1 => array:2 [
              "nombre" => "Hao"
              "apellidos" => "Wu"
            ]
            2 => array:2 [
              "nombre" => "Ke&#8208;Feng"
              "apellidos" => "Tang"
            ]
            3 => array:2 [
              "nombre" => "Yi&#8208;Ming"
              "apellidos" => "Fan"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "pt"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S0365059621002257"
        "doi" => "10.1016/j.abd.2020.08.027"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0365059621002257?idApp=UINPBA00008Z"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2666275221002319?idApp=UINPBA00008Z"
    "url" => "/26662752/0000009600000006/v2_202111200533/S2666275221002319/v2_202111200533/pt/main.assets"
  ]
  "itemAnterior" => array:19 [
    "pii" => "S2666275221002204"
    "issn" => "26662752"
    "doi" => "10.1016/j.abdp.2021.09.012"
    "estado" => "S300"
    "fechaPublicacion" => "2021-11-01"
    "aid" => "439"
    "copyright" => "Sociedade Brasileira de Dermatologia"
    "documento" => "article"
    "crossmark" => 1
    "licencia" => "http://creativecommons.org/licenses/by/4.0/"
    "subdocumento" => "sco"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:1 [
      "total" => 0
    ]
    "pt" => array:10 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Carta &#8208; Investiga&#231;&#227;o</span>"
      "titulo" => "Avalia&#231;&#227;o da efic&#225;cia do&#160;5&#8208;fluorouracil 5&#37;&#160;t&#243;pico intermitente e da nicotinamida oral no tratamento do campo de canceriza&#231;&#227;o cut&#226;neo&#58; um ensaio cl&#237;nico randomizado"
      "tienePdf" => "pt"
      "tieneTextoCompleto" => "pt"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "784"
          "paginaFinal" => "787"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "pt" => true
      ]
      "contienePdf" => array:1 [
        "pt" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0005"
          "etiqueta" => "Figura 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 1440
              "Ancho" => 2167
              "Tamanyo" => 135747
            ]
          ]
          "descripcion" => array:1 [
            "pt" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Contagem das ceratoses act&#237;nicas no T0 e no T120 para os grupos nicotinamida oral&#44; placebo&#44; 5FU e filtro solar t&#243;picos&#58; melhora em todos os grupos com o tempo&#44; com superioridade ao grupo em uso de 5FU t&#243;pico&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Eliane Roio Ferreira, Anna Carolina Miola, Thania Rios Rossi Lima, Juliano Vilaverde Schmitt, Luciana Patricia Fernandes Abbade, H&#233;lio Amante Miot"
          "autores" => array:6 [
            0 => array:2 [
              "nombre" => "Eliane Roio"
              "apellidos" => "Ferreira"
            ]
            1 => array:2 [
              "nombre" => "Anna Carolina"
              "apellidos" => "Miola"
            ]
            2 => array:2 [
              "nombre" => "Thania Rios Rossi"
              "apellidos" => "Lima"
            ]
            3 => array:2 [
              "nombre" => "Juliano Vilaverde"
              "apellidos" => "Schmitt"
            ]
            4 => array:2 [
              "nombre" => "Luciana Patricia Fernandes"
              "apellidos" => "Abbade"
            ]
            5 => array:2 [
              "nombre" => "H&#233;lio Amante"
              "apellidos" => "Miot"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "pt"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S0365059621002142"
        "doi" => "10.1016/j.abd.2020.09.012"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0365059621002142?idApp=UINPBA00008Z"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2666275221002204?idApp=UINPBA00008Z"
    "url" => "/26662752/0000009600000006/v2_202111200533/S2666275221002204/v2_202111200533/pt/main.assets"
  ]
  "pt" => array:17 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Carta &#8208; Investiga&#231;&#227;o</span>"
    "titulo" => "Seguran&#231;a e efic&#225;cia de 104 semanas de dupilumabe no tratamento de dermatite at&#243;pica grave&#46; A experi&#234;ncia de cinco unidades dermatol&#243;gicas de refer&#234;ncia na Espanha"
    "tieneTextoCompleto" => true
    "saludo" => "<span class="elsevierStyleItalic">Prezado Editor&#44;</span>"
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "787"
        "paginaFinal" => "790"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "Jose Juan Pereyra&#8208;Rodriguez, Javier Dominguez&#8208;Cruz, Jose Carlos Armario&#8208;Hita, Ricardo Ruiz&#8208;Villaverde"
        "autores" => array:4 [
          0 => array:3 [
            "nombre" => "Jose Juan"
            "apellidos" => "Pereyra&#8208;Rodriguez"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
          1 => array:3 [
            "nombre" => "Javier"
            "apellidos" => "Dominguez&#8208;Cruz"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
          2 => array:3 [
            "nombre" => "Jose Carlos"
            "apellidos" => "Armario&#8208;Hita"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
            ]
          ]
          3 => array:4 [
            "nombre" => "Ricardo"
            "apellidos" => "Ruiz&#8208;Villaverde"
            "email" => array:1 [
              0 => "ricardo.ruiz.villaverde.sspa@juntadeandalucia.es"
            ]
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">c</span>"
                "identificador" => "aff0015"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:3 [
          0 => array:3 [
            "entidad" => "Unidade de Dermatologia&#44; Hospital Universitario Virgen del Rocio&#44; Sevilha&#44; Espanha"
            "etiqueta" => "a"
            "identificador" => "aff0005"
          ]
          1 => array:3 [
            "entidad" => "Unidade de Dermatologia&#44; Hospital Universitario Puerto Real&#44; C&#225;diz&#44; Espanha"
            "etiqueta" => "b"
            "identificador" => "aff0010"
          ]
          2 => array:3 [
            "entidad" => "Unidade de Dermatologia&#44; Hospital Universitario San Cecilio&#44; Granada&#44; Espanha"
            "etiqueta" => "c"
            "identificador" => "aff0015"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Autor para correspond&#234;ncia&#46;"
          ]
        ]
      ]
    ]
    "resumenGrafico" => array:2 [
      "original" => 0
      "multimedia" => array:7 [
        "identificador" => "fig0010"
        "etiqueta" => "Figura 2"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr2.jpeg"
            "Alto" => 1366
            "Ancho" => 2175
            "Tamanyo" => 91016
          ]
        ]
        "descripcion" => array:1 [
          "pt" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Evolu&#231;&#227;o do DLQI da linha de base at&#233; a semana 104&#46; <span class="elsevierStyleItalic">DLQI</span>&#44; <span class="elsevierStyleItalic">Dermatology Life Quality Index</span>&#46;</p>"
        ]
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">A dermatite at&#243;pica &#40;DA&#41; &#233; uma doen&#231;a multifatorial resultante da intera&#231;&#227;o de predisposi&#231;&#227;o gen&#233;tica&#44; gatilhos ambientais&#44; perda da fun&#231;&#227;o de barreira da pele e desregula&#231;&#227;o imunol&#243;gica do tipo 2&#46; O manejo das formas leves de DA inclui o uso de emolientes&#44; corticosteroides t&#243;picos ou inibidores da calcineurina e fototerapia&#44; enquanto os agentes imunossupressores sist&#234;micos&#44; como corticosteroides orais e ciclosporina A &#40;CsA&#41;&#44; s&#227;o indicados para casos refrat&#225;rios graves&#46;<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">1</span></a> Entretanto&#44; os casos graves geralmente n&#227;o s&#227;o controlados de maneira adequada com nenhuma dessas terapias&#44; exigindo uma etapa adicional para atingir o controle cl&#237;nico&#46;<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">2</span></a> Recentemente&#44; a FDA e a EMA autorizaram o uso de dupilumabe&#44; um tratamento direcionado &#224;s citocinas Th2 IL&#8208;4 e IL&#8208;13 que se mostrou eficaz no controle dos sinais e sintomas de DA&#46; A experi&#234;ncia cl&#237;nica com o dupilumabe mostra uma efic&#225;cia semelhante em compara&#231;&#227;o com os ensaios cl&#237;nicos randomizados&#44; mas ainda n&#227;o se sabe como esse medicamento se comportar&#225; em longo prazo na pr&#225;tica m&#233;dica de rotina&#46;<a class="elsevierStyleCrossRefs" href="#bib0040"><span class="elsevierStyleSup">3&#8211;5</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">Realizou&#8208;se uma revis&#227;o retrospectiva de prontu&#225;rios de 30 pacientes de cinco unidades de dermatologia de refer&#234;ncia da Andaluzia &#40;Hospital Virgen del Rocio&#8208;Sevilla&#59; Hospital Juan Ramon Jimenez&#8208;Huelva&#59; Hospital Universitario de Puerto Real&#8208;C&#225;diz&#59; Hospital Reina Sofia&#8208;C&#243;rdoba e Hospital Universitario San Cecilio&#8208;Granada&#41; inclu&#237;dos no uso compassivo na Espanha de dupilumabe para pacientes adultos com DA moderada a grave&#44; de novembro de 2017 a fevereiro de 2020&#46; De acordo com as recomenda&#231;&#245;es do programa de uso compassivo para prescri&#231;&#227;o de dupilumabe&#44; os crit&#233;rios de inclus&#227;o foram idade &#8805; 18 anos&#44; doen&#231;a grave definida por &#205;ndice de &#193;rea e Gravidade de Eczema &#40;EASI&#44; <span class="elsevierStyleItalic">Eczema Area and Severity Index</span>&#41; basal &#8805; 16 e resposta inadequada&#47;intoler&#226;ncia a CsA ou desaconselhamento m&#233;dico para o tratamento com CsA&#46; Pacientes com qualquer comorbidade psiqui&#225;trica documentada foram exclu&#237;dos do estudo&#46;</p><p id="par0015" class="elsevierStylePara elsevierViewall">Todos os pacientes foram tratados com dupilumabe subcut&#226;neo 300<span class="elsevierStyleHsp" style=""></span>mg a cada duas semanas ap&#243;s uma dose de ataque de 600<span class="elsevierStyleHsp" style=""></span>mg&#46; Tratamentos concomitantes com corticosteroides t&#243;picos ou inibidores da calcineurina foram permitidos&#46; Todos os pacientes concordaram com o regime de tratamento e assinaram um termo de consentimento por escrito para autorizar a extra&#231;&#227;o de dados relevantes de seus prontu&#225;rios&#46; Os dados coletados inclu&#237;ram idade&#44; tempo de evolu&#231;&#227;o da doen&#231;a&#44; hist&#243;ria pessoal &#40;incluindo comorbidades&#41; e tratamentos sist&#234;micos&#47; biol&#243;gicos anteriores&#46; A gravidade da doen&#231;a foi medida pela ferramenta Scoring Atopic Dermatitis &#40;SCORAD&#41; e Escala Visual Anal&#243;gica &#40;EVA&#41; de prurido na consulta inicial e nas semanas de acompanhamento 4&#44; 12&#44; 24&#44; 52&#44; 76 e 104&#46; A qualidade de vida foi avaliada pelo <span class="elsevierStyleItalic">Dermatology Life Quality Index</span> &#40;DLQI&#41;&#46;</p><p id="par0020" class="elsevierStylePara elsevierViewall">As caracter&#237;sticas basais s&#227;o apresentadas na <a class="elsevierStyleCrossRef" href="#tbl0005">tabela 1</a>&#46; A popula&#231;&#227;o estudada apresentou uma carga de doen&#231;a substancial&#44; com uma m&#233;dia de 25&#44;7 anos de evolu&#231;&#227;o de DA&#46; As comorbidades mais comuns foram rinite al&#233;rgica &#40;55&#44;5&#37;&#41;&#44; asma &#40;37&#37;&#41; e conjuntivite &#40;33&#44;4&#37;&#41;&#46; Essas comorbidades foram mais comuns em pacientes com tratamento mais prolongado com imunossupressores&#46; Todos os pacientes tinham recebido tratamento anterior com corticosteroides orais e 96&#44;3&#37; tinham sido tratados com ciclosporina&#46;<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">3</span></a> A efetividade do tratamento com dupilumabe foi avaliada nas semanas 4&#44; 12&#44; 24&#44; 52 e 104&#46; A porcentagem m&#233;dia de mudan&#231;a na SCORAD &#233; mostrada na <a class="elsevierStyleCrossRef" href="#fig0005">figura 1</a>&#44; enquanto a evolu&#231;&#227;o do DLQI &#233; mostrada na <a class="elsevierStyleCrossRef" href="#fig0010">figura 2</a>&#46;</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><elsevierMultimedia ident="fig0005"></elsevierMultimedia><elsevierMultimedia ident="fig0010"></elsevierMultimedia><p id="par0025" class="elsevierStylePara elsevierViewall">Na linha de base&#44; o escore na SCORAD era de 59&#44;4&#44; enquanto a EVA de prurido era de 8&#44;3&#46; Na consulta de seguimento da semana 104&#44; o SCORAD diminuiu para 10&#44;7 &#40;&#8722;82&#37;&#41; e a EVA de prurido reduziu para 2&#44;9 &#40;&#8722;65&#37;&#41;&#46; Em rela&#231;&#227;o &#224; QV&#44; o valor basal do DLQI foi 19&#44; chegando a 4&#44;3 &#40;&#8722;77&#44;4&#37;&#41; no mesmo ponto de corte&#46; O perfil de seguran&#231;a foi favor&#225;vel&#44; com relato de tr&#234;s casos de conjuntivite leve&#44; tratada positivamente sem suspens&#227;o de Dupilumabe&#46; Um exemplo da evolu&#231;&#227;o ap&#243;s 16 semanas de tratamento &#233; mostrado na linha basal &#40;<a class="elsevierStyleCrossRef" href="#fig0015">fig&#46; 3</a>&#41; e ap&#243;s 16 semanas &#40;<a class="elsevierStyleCrossRef" href="#fig0020">fig&#46; 4</a>&#41;&#46;</p><elsevierMultimedia ident="fig0015"></elsevierMultimedia><elsevierMultimedia ident="fig0020"></elsevierMultimedia><p id="par0030" class="elsevierStylePara elsevierViewall">Este estudo multic&#234;ntrico retrospectivo em uma coorte de 30 pacientes com DA grave implica no seguimento mais longo publicado at&#233; o momento da experi&#234;ncia cl&#237;nica com dupilumabe e confirma a efic&#225;cia desse agente para casos refrat&#225;rios&#46; Uma redu&#231;&#227;o estatisticamente significativa no SCORAD foi alcan&#231;ada na semana 4 e mantida at&#233; a semana 104&#46; A melhora cl&#237;nica foi acompanhada por uma melhora consider&#225;vel da qualidade de vida&#44; medida pelo DLQI&#44; e o sintoma mais inc&#244;modo&#44; prurido&#44; foi avaliado por meio da EVA de prurido&#46; O dupilumabe foi bem tolerado na maioria dos indiv&#237;duos&#59; apenas 10&#37; dos pacientes apresentaram conjuntivite&#46; Esses resultados est&#227;o de acordo com o que foi registrado em ensaios cl&#237;nicos&#44; mas contrastam com outros estudos cl&#237;nicos&#44; que relataram sintomas oculares em at&#233; 62&#37; dos casos&#46;<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">5</span></a> De acordo com nossa experi&#234;ncia&#44; o uso de col&#237;rios de emuls&#227;o lip&#237;dica combinado a col&#237;rios com &#225;cido hialur&#244;nico como medida profil&#225;tica pode ter um efeito protetor contra olhos secos e prurido ocular&#44; que podem ter um papel fundamental no desenvolvimento de conjuntivite&#46; Rea&#231;&#245;es no local da inje&#231;&#227;o n&#227;o foram relatadas pelos pacientes&#46; As limita&#231;&#245;es do estudo incluem sua natureza retrospectiva e o pequeno tamanho da amostra&#46;</p><p id="par0035" class="elsevierStylePara elsevierViewall">Este estudo cl&#237;nico confirmou que o dupilumabe &#233; um tratamento eficaz em pacientes com DA grave e fornece o seguimento mais longo publicado at&#233; o momento&#46;</p><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0005">Suporte financeiro</span><p id="par0040" class="elsevierStylePara elsevierViewall">Nenhum&#46;</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Contribui&#231;&#227;o dos autores</span><p id="par0045" class="elsevierStylePara elsevierViewall">Jose Juan Pereyra&#8208;Rodriguez&#58; Obten&#231;&#227;o de dados&#59; edi&#231;&#227;o&#59; concep&#231;&#227;o e desenho do estudo&#59; reda&#231;&#227;o&#59; revis&#227;o cr&#237;tica&#46;</p><p id="par0050" class="elsevierStylePara elsevierViewall">Javier Dominguez&#8208;Cruz&#58; Obten&#231;&#227;o de dados&#59; edi&#231;&#227;o&#59; projeto&#59; revis&#227;o cr&#237;tica&#46;</p><p id="par0055" class="elsevierStylePara elsevierViewall">Jose Carlos Armario&#8208;Hita&#58; Obten&#231;&#227;o de dados&#59; edi&#231;&#227;o&#59; projeto&#59; revis&#227;o cr&#237;tica&#46;</p><p id="par0060" class="elsevierStylePara elsevierViewall">Ricardo Ruiz Villaverde&#58; Obten&#231;&#227;o de dados&#59; edi&#231;&#227;o&#59; concep&#231;&#227;o e desenho do estudo&#59; reda&#231;&#227;o&#59; revis&#227;o cr&#237;tica&#46;</p></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Conflito de interesses</span><p id="par0065" class="elsevierStylePara elsevierViewall">Nenhum&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:4 [
        0 => array:2 [
          "identificador" => "sec0005"
          "titulo" => "Suporte financeiro"
        ]
        1 => array:2 [
          "identificador" => "sec0010"
          "titulo" => "Contribui&#231;&#227;o dos autores"
        ]
        2 => array:2 [
          "identificador" => "sec0015"
          "titulo" => "Conflito de interesses"
        ]
        3 => array:1 [
          "titulo" => "Refer&#234;ncias"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "fechaRecibido" => "2020-04-20"
    "fechaAceptado" => "2020-08-24"
    "NotaPie" => array:2 [
      0 => array:2 [
        "etiqueta" => "&#9734;"
        "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Como citar este artigo&#58; Pereyra&#8208;Rodriguez JJ&#44; Dominguez&#8208;Cruz J&#44; Armario&#8208;Hita JC&#44; Villaverde RR&#46; 104&#8208;week safety and effectiveness of dupilumab in the treatment of severe atopic dermatitis&#46; The experience of 5 reference dermatology units in Spain&#46; An Bras Dermatol&#46; 2021&#59;96&#58;787&#8211;90&#46;</p>"
      ]
      1 => array:2 [
        "etiqueta" => "&#9734;&#9734;"
        "nota" => "<p class="elsevierStyleNotepara" id="npar0010">Trabalho realizado no Hospital Universitario San Cecilio&#44; Granada&#44; Espanha&#46;</p>"
      ]
    ]
    "multimedia" => array:5 [
      0 => array:7 [
        "identificador" => "fig0005"
        "etiqueta" => "Figura 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 1184
            "Ancho" => 2175
            "Tamanyo" => 87428
          ]
        ]
        "descripcion" => array:1 [
          "pt" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Altera&#231;&#227;o percentual m&#233;dia no escore de dermatite at&#243;pica &#40;SCORAD&#44; <span class="elsevierStyleItalic">Scoring Atopic Dermatitis</span>&#41; desde a linha de base at&#233; a semana 104 em pacientes tratados com dupilumabe&#46;</p>"
        ]
      ]
      1 => array:7 [
        "identificador" => "fig0010"
        "etiqueta" => "Figura 2"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr2.jpeg"
            "Alto" => 1366
            "Ancho" => 2175
            "Tamanyo" => 91016
          ]
        ]
        "descripcion" => array:1 [
          "pt" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Evolu&#231;&#227;o do DLQI da linha de base at&#233; a semana 104&#46; <span class="elsevierStyleItalic">DLQI</span>&#44; <span class="elsevierStyleItalic">Dermatology Life Quality Index</span>&#46;</p>"
        ]
      ]
      2 => array:7 [
        "identificador" => "fig0015"
        "etiqueta" => "Figura 3"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr3.jpeg"
            "Alto" => 565
            "Ancho" => 1305
            "Tamanyo" => 86068
          ]
        ]
        "descripcion" => array:1 [
          "pt" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Estado basal em um paciente da presente s&#233;rie &#40;SCORAD 64&#41;&#46;</p>"
        ]
      ]
      3 => array:7 [
        "identificador" => "fig0020"
        "etiqueta" => "Figura 4"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr4.jpeg"
            "Alto" => 446
            "Ancho" => 1305
            "Tamanyo" => 69275
          ]
        ]
        "descripcion" => array:1 [
          "pt" => "<p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Dezesseis semanas ap&#243;s tratamento com Dupilumab &#40;SCORAD 16&#41;&#46;</p>"
        ]
      ]
      4 => array:8 [
        "identificador" => "tbl0005"
        "etiqueta" => "Tabela 1"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at1"
            "detalle" => "Tabela "
            "rol" => "short"
          ]
        ]
        "tabla" => array:1 [
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Caracter&#237;stica&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">M&#233;dia&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleItalic">Idade&#44; anos &#40;varia&#231;&#227;o&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">40&#44;4 &#40;19&#8211;56&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleItalic">Sexo &#40;masculino&#44; &#37;&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">70&#37; &#40;21&#47;30&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleItalic">Anos de evolu&#231;&#227;o de DA&#44; anos &#40;varia&#231;&#227;o&#41;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">28&#44;5 &#40;10&#8211;44&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " colspan="2" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleItalic">Comorbidades &#40;&#37;&#41;</span></td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>P&#243;lipos nasais&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">16&#44;6&#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Conjuntivite&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">36&#44;8&#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Asma extr&#237;nseca&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">22&#44;2&#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Rinite al&#233;rgica&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">50&#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Alergias alimentares&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">22&#44;2&#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " colspan="2" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " colspan="2" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleItalic">Tratamento anterior</span></td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Corticosteroides sist&#234;micos orais&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">100&#37; &#40;dura&#231;&#227;o m&#233;dia&#58; 23&#44;7 meses&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Ciclosporina oral&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">94&#44;4&#37; &#40;dura&#231;&#227;o m&#233;dia&#58; 19&#44;8 meses&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Fototerapia &#40;NB&#8208;UVB&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">33&#44;3&#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>SCORAD basal&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">59&#44;4&#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>EVA de prurido basal&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">8&#44;3&#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>DLQI basal&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">19&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab2750910.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "pt" => "<p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Caracter&#237;sticas basais dos pacientes</p>"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "Refer&#234;ncias"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0015"
          "bibliografiaReferencia" => array:5 [
            0 => array:3 [
              "identificador" => "bib0030"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Atopic dermatitis in adults&#58; a diagnostic challenge"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "J&#46;F&#46; Silvestre Salvador"
                            1 => "D&#46; Romero-P&#233;rez"
                            2 => "B&#46; Encabo-Dur&#225;n"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.18176/jiaci.0138"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Investig Allergol Clin Immunol&#46;"
                        "fecha" => "2017"
                        "volumen" => "27"
                        "paginaInicial" => "78"
                        "paginaFinal" => "88"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28071589"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0035"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Changing perspectives in atopic dermatitis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "E&#46; Serra-Baldrich"
                            1 => "J&#46;O&#46; de Frutos"
                            2 => "I&#46; J&#225;uregui"
                            3 => "J&#46;C&#46; Armario-Hita"
                            4 => "J&#46;F&#46; Silvestre"
                            5 => "L&#46; Herraez"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Allergol Immunopathol&#46;"
                        "fecha" => "2018"
                        "volumen" => "46"
                        "paginaInicial" => "397"
                        "paginaFinal" => "412"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0040"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Dupilumab&#58; short&#8208;term effectiveness and security in real clinical practice &#8211; A retrospective multicentric study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:6 [
                            0 => "R&#46; Ruiz-Villaverde"
                            1 => "J&#46; Dominguez-Cruz"
                            2 => "J&#46;C&#46; Armario-Hita"
                            3 => "L&#46; Martinez-Pilar"
                            4 => "S&#46; Alcantara-Luna"
                            5 => "J&#46;J&#46; Pereyra-Rodriguez"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/jdv.15118"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Eur Acad Dermatol Venereol&#46;"
                        "fecha" => "2019"
                        "volumen" => "33"
                        "paginaInicial" => "e21"
                        "paginaFinal" => "e22"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29888527"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0045"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Treatment of moderate&#8208;to&#8208;severe atopic dermatitis with dupilumab in real clinical practice&#58; a multicentre&#44; retrospective case series"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46;C&#46; Armario-Hita"
                            1 => "J&#46; Pereyra-Rodriguez"
                            2 => "J&#46;F&#46; Silvestre"
                            3 => "R&#46; Ruiz-Villaverde"
                            4 => "A&#46; Valero"
                            5 => "R&#46; Izu-Belloso"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/bjd.18041"
                      "Revista" => array:6 [
                        "tituloSerie" => "Br J Dermatol&#46;"
                        "fecha" => "2019"
                        "volumen" => "181"
                        "paginaInicial" => "1072"
                        "paginaFinal" => "1074"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/31021399"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0050"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Clinical Response and Quality of Life in Patients with Severe Atopic Dermatitis Treated with Dupilumab&#58; A Single&#8208;Center Real&#8208;Life Experience"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "S&#46; Ferrucci"
                            1 => "G&#46; Casazza"
                            2 => "L&#46; Angileri"
                            3 => "S&#46; Tavecchio"
                            4 => "F&#46; Germiniasi"
                            5 => "E&#46; Berti"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:4 [
                        "tituloSerie" => "J Clin Med&#46;"
                        "fecha" => "2020"
                        "volumen" => "9"
                        "paginaInicial" => "791"
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "pt"
  "url" => "/26662752/0000009600000006/v2_202111200533/S2666275221002368/v2_202111200533/pt/main.assets"
  "Apartado" => array:4 [
    "identificador" => "82068"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Carta - Investiga&#231;&#227;o"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/26662752/0000009600000006/v2_202111200533/S2666275221002368/v2_202111200533/pt/main.pdf?idApp=UINPBA00008Z&text.app=https://clinics.elsevier.es/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2666275221002368?idApp=UINPBA00008Z"
]
Article information
ISSN: 26662752
Original language: Portuguese
The statistics are updated each day
Year/Month Html Pdf Total
2024 November 15 5 20
2024 October 324 97 421
2024 September 347 87 434
2024 August 281 130 411
2024 July 293 120 413
2024 June 196 97 293
2024 May 228 94 322
2024 April 201 110 311
2024 March 194 82 276
2024 February 314 90 404
2024 January 198 51 249
2023 December 153 60 213
2023 November 161 93 254
2023 October 172 65 237
2023 September 195 93 288
2023 August 166 35 201
2023 July 174 42 216
2023 June 150 70 220
2023 May 161 43 204
2023 April 131 26 157
2023 March 161 46 207
2023 February 128 44 172
2023 January 96 47 143
2022 December 115 42 157
2022 November 139 75 214
2022 October 179 65 244
2022 September 86 70 156
2022 August 98 78 176
2022 July 95 75 170
2022 June 82 71 153
2022 May 63 73 136
2022 April 66 82 148
2022 March 76 93 169
2022 February 46 53 99
2022 January 142 123 265
2021 December 104 95 199
2021 November 86 65 151
2021 October 8 21 29
Show all

Follow this link to access the full text of the article

Idiomas
Anais Brasileiros de Dermatologia
en pt
Cookies policy Política de cookies
To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.